Spinal muscular atrophy (SMA) is a devastating neuromuscular disease that affects children and young adults. The degeneration of spinal motor neurons, which are primarily involved in this disease, results in progressive muscular weakness and atrophy. As of 2016, there is no effective clinical treatment available for SMA patients, even if a large number of therapeutic approaches are being tested worldwide.Stem cells have been considered as a potential therapeutic strategy due to their plasticity and ability to direct differentiation in response to extracellular signals. Current cell-based therapies employ multiple types of stem cells to modify disease pathophysiology. This is theoretically achieved by either supporting neurons and glial cells through the release of neurotrophic factors, or directly replacing them.This chapter focuses on the therapeutic potential of different subtypes of human pluripotent stem cells and their derived phenotypes for SMA. This chapter also briefly describes their contribution in disease pathogenesis understanding. Finally, the chapter discusses the main challenges to overcome for stem cell therapeutic clinical translation.
Addressing Cell Therapy for Spinal Muscular Atrophy: Open Issues and Future Perspectives / I. Faravelli, S.P. Corti - In: Spinal Muscular Atrophy : Disease Mechanisms and Therapy / [a cura di] C.J. Sumner, S. Paushkin, C.-P. Ko. - [s.l] : Elsevier Inc., 2016. - ISBN 9780128036860. - pp. 357-367 [10.1016/B978-0-12-803685-3.00022-7]
Addressing Cell Therapy for Spinal Muscular Atrophy: Open Issues and Future Perspectives
I. FaravelliWriting – Original Draft Preparation
;S.P. Corti
Writing – Original Draft Preparation
2016
Abstract
Spinal muscular atrophy (SMA) is a devastating neuromuscular disease that affects children and young adults. The degeneration of spinal motor neurons, which are primarily involved in this disease, results in progressive muscular weakness and atrophy. As of 2016, there is no effective clinical treatment available for SMA patients, even if a large number of therapeutic approaches are being tested worldwide.Stem cells have been considered as a potential therapeutic strategy due to their plasticity and ability to direct differentiation in response to extracellular signals. Current cell-based therapies employ multiple types of stem cells to modify disease pathophysiology. This is theoretically achieved by either supporting neurons and glial cells through the release of neurotrophic factors, or directly replacing them.This chapter focuses on the therapeutic potential of different subtypes of human pluripotent stem cells and their derived phenotypes for SMA. This chapter also briefly describes their contribution in disease pathogenesis understanding. Finally, the chapter discusses the main challenges to overcome for stem cell therapeutic clinical translation.File | Dimensione | Formato | |
---|---|---|---|
Faravelli d.pdf
accesso riservato
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
356.88 kB
Formato
Adobe PDF
|
356.88 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.